It’s too bad Naproxen is being lumped in with the COX-2s. Its data is so preliminary, it may not even be statistically significant. I guess physicians aren’t taking any chances.
Related posts:
- The numbers behind the torcetrapib decision
- Carlat vs Medscape: Escalation
- Poll: How effective is the HIV vaccine, and will it affect public health?
- Poll: Doctors and nurses should get vaccinated against the seasonal flu and H1N1 influenza
- Poll: Should we loosen the restrictions on organ donation?
- Instant first aid
- Instant WBC?
KevinMD.com on Facebook
{ 1 comment }
I think it’s unfortunate too since the evidence doesn’t really seem to support the warning. The Wall Street Journal had some good articles on it in their health column. It seems to me that they are just being reactionary after the cox-2s, and I don’t know that that’s good for any of us.
Oh well, I’ll continue taking my Alleve when needed until someone gives me some hard numbers
Comments on this entry are closed.